Cardinal Health Inc (CAH) is slightly overvalued and EDAP TMS SA ADR (FOCL) is overvalued.
Both trade above our estimate of their intrinsic value. CAH is the closer of the two: -9%, against -91% for FOCL.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $203.47; the price of $222.04 is 9% above that value, and 80% of that value comes from beyond year five.
Leak Score 43/100 on 8 of 12 signals
A 1.5x revenue multiple, discounted for its losses, values the shares at $2.24; the price of $4.27 is 91% above that value.
Leak Score 0/100 on 2 of 12 signals
| Metric | CAH | FOCL |
|---|---|---|
| Verdict | Slightly overvalued | Overvalued |
| Price | $222.04 | $4.27 |
| Intrinsic value | $203.47 | $2.24 |
| Margin of safety | -9% | -91% |
| Leak Score | 43/100 (8/12) | 0/100 (2/12) |
| Market cap | $51.6B | $160M |
| Revenue growth, 5 years | 9.4% | 8.3% |
| Operating margin | 1.3% | -39.3% |
| Net margin | 0.7% | -56.3% |
| Return on equity | — | -263.8% |
| P/E | 30.7x | — |
| Forward P/E | 15.8x | — |
| Dividend yield | 0.9% | — |